Relationship Between a Frailty-Related Phenotype and Progressive Deterioration of the Immune System in HIV-Infected Men

Context:Immunological similarities have been noted between HIV-infected individuals and older HIV-negative adults. Immunologic alterations with aging have been noted in frailty in older adults, a clinical syndrome of high risk for mortality and other adverse outcomes. Using a frailty-related phenotype (FRP), we investigated in the Multicenter AIDS Cohort Study whether progressive deterioration of the immune system among HIV-positive individuals independently predicts onset of FRP. Methods:FRP was evaluated semiannually in 1046 HIV-infected men from 1994 to 2005. CD4 T-cell count and plasma viral load were evaluated as predictors of FRP by logistic regression (generalized estimating equations), adjusting for age, ethnicity, educational level, AIDS status, and treatment era [pre-highly active antiretroviral therapy (HAART) (1994-1995) and HAART (1996-1999 and 2000-2005)]. Results:Adjusted prevalences of FRP remained low for CD4 T-cell counts >400 cells per cubic millimeter and increased exponentially and significantly for lower counts. Results were unaffected by treatment era. After 1996, CD4 T-cell count, but not plasma viral load, was independently associated with FRP. Conclusions:CD4 T-cell count predicted the development of a FRP among HIV-infected men, independent of HAART use. This suggests that compromise of the immune system in HIV-infected individuals contributes to the systemic physiologic dysfunction of frailty.

[1]  R. Varadhan,et al.  Opinion section on frailty , 2008, Mechanisms of Ageing and Development.

[2]  V. Appay,et al.  Immune activation and inflammation in HIV‐1 infection: causes and consequences , 2008, The Journal of pathology.

[3]  J. Margolick,et al.  HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  W. Ershler A gripping reality: oxidative stress, inflammation, and the pathway to frailty. , 2007, Journal of applied physiology.

[5]  L. Fried,et al.  Inflammation and Frailty in Older Women , 2007, Journal of the American Geriatrics Society.

[6]  B. Autran,et al.  Accelerated immune senescence and HIV-1 infection , 2007, Experimental Gerontology.

[7]  L. Ferrucci,et al.  Frailty of older age: the role of the endocrine--immune interaction. , 2006, Current pharmaceutical design.

[8]  S. Studenski,et al.  Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults , 2006, Journal of the American Geriatrics Society.

[9]  L. Ferrucci,et al.  Phenotype of frailty: characterization in the women's health and aging studies. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  R. Greenblatt,et al.  Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004 , 2005, AIDS.

[11]  Luigi Ferrucci,et al.  From bedside to bench: research agenda for frailty. , 2005, Science of aging knowledge environment : SAGE KE.

[12]  C. Rinaldo,et al.  Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches. , 2005, AIDS reviews.

[13]  Jerome H. Kim,et al.  HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  L. Ferrucci,et al.  Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  G. Pawelec,et al.  Human immunosenescence: is it infectious? , 2005, Immunological reviews.

[16]  R. Effros,et al.  The role of CD8+ T‐cell replicative senescence in human aging , 2005, Discovery medicine.

[17]  L. Fried,et al.  Chronic Cytomegalovirus Infection and Inflammation Are Associated with Prevalent Frailty in Community‐Dwelling Older Women , 2005, Journal of the American Geriatrics Society.

[18]  J. Margolick,et al.  T cell subsets and mortality in older community-dwelling women , 2005, Experimental Gerontology.

[19]  F. Miedema,et al.  Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. , 2005, Immunology letters.

[20]  C. Franceschi,et al.  Chronic antigenic load and apoptosis in immunosenescence. , 2005, Trends in immunology.

[21]  G. Mcgwin,et al.  Factors associated with chronic renal failure in HIV-infected ambulatory patients , 2004, AIDS.

[22]  J. Phair,et al.  Update on the virologic and immunologic response to highly active antiretroviral therapy , 2004, Current infectious disease reports.

[23]  Bruce M Psaty,et al.  The presence of frailty in elderly persons with chronic renal insufficiency. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  L. Lipsitz Physiological complexity, aging, and the path to frailty. , 2004, Science of aging knowledge environment : SAGE KE.

[25]  A. Vallejo,et al.  T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. , 2004, Trends in molecular medicine.

[26]  J. Walston,et al.  Frailty--the search for underlying causes. , 2004, Science of aging knowledge environment : SAGE KE.

[27]  R. Westendorp,et al.  Lymphocyte Count and Mortality Risk in Older Persons. The Leiden 85‐Plus Study , 2003, Journal of the American Geriatrics Society.

[28]  W. Hazzard,et al.  Principles of Geriatric Medicine and Gerontology , 2003 .

[29]  M. Lederman,et al.  Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. , 2003, The Journal of infectious diseases.

[30]  G. Pawelec,et al.  Basic biology and clinical impact of immunosenescence , 2003, Biogerontology.

[31]  M. Schroll,et al.  Predicting death from tumour necrosis factor‐alpha and interleukin‐6 in 80‐year‐old people , 2003, Clinical and experimental immunology.

[32]  G. Martínez,et al.  Contribution to characterization of oxidative stress in HIV/AIDS patients. , 2003, Pharmacological research.

[33]  B. Pedersen,et al.  Age-related inflammatory cytokines and disease. , 2003, Immunology and allergy clinics of North America.

[34]  Helle Bruunsgaard,et al.  Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. , 2003, European cytokine network.

[35]  Suzanne G. Leveille,et al.  Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum Levels , 2002, Journal of the American Geriatrics Society.

[36]  S. Rowland-Jones,et al.  Premature ageing of the immune system: the cause of AIDS? , 2002, Trends in immunology.

[37]  Mark Dybul,et al.  Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV* , 2002, Annals of Internal Medicine.

[38]  J W Rowe,et al.  Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging , 2002, Neurology.

[39]  A. Dobs,et al.  Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. , 2002, American journal of epidemiology.

[40]  G. Wittert,et al.  The low dose dexamethasone suppression test: Effect of time of administration and dose , 2002, Journal of endocrinological investigation.

[41]  M. Hernán,et al.  Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. , 2002, American journal of epidemiology.

[42]  J. Margolick,et al.  Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy. , 2001 .

[43]  R. Effros Long-term immunological memory against viruses , 2001, Mechanisms of Ageing and Development.

[44]  R. Effros,et al.  Ageing of lymphocytes and lymphocytes in the aged. , 2000, Immunology today.

[45]  J. Rabkin,et al.  Psychological Effects of HAART: A 2-Year Study , 2000, Psychosomatic medicine.

[46]  P Royston,et al.  The use of fractional polynomials to model continuous risk variables in epidemiology. , 1999, International journal of epidemiology.

[47]  L. Fried,et al.  Frailty and the older man. , 1999, The Medical clinics of North America.

[48]  Luigi Ferrucci,et al.  Serum IL‐6 Level and the Development of Disability in Older Persons , 1999, Journal of the American Geriatrics Society.

[49]  A Muñoz,et al.  Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. , 1998, JAMA.

[50]  B. Johansson,et al.  Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study , 1998, Mechanisms of Ageing and Development.

[51]  C. Gibert,et al.  Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[52]  S. Grinspoon,et al.  Diagnosis and treatment of endocrine disorders in the HIV-infected patient. , 1998, Journal of the International Association of Physicians in AIDS Care.

[53]  M. Gougerot-Pocidalo,et al.  Oxidative stress in human immunodeficiency virus infection , 1997, Cellular and Molecular Life Sciences CMLS.

[54]  J. Rabkin,et al.  A 'second life' agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. , 1997, Archives of general psychiatry.

[55]  K. Kreuzer,et al.  Pathogenesis and pathophysiology of anemia in HIV infection , 1997, Annals of Hematology.

[56]  D M Buchner,et al.  Unstable disability and the fluctuations of frailty. , 1997, Age and ageing.

[57]  I. Rea,et al.  Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. , 1996, Gerontology.

[58]  C. Harley,et al.  Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. , 1996, AIDS.

[59]  D. Rubin Multiple Imputation After 18+ Years , 1996 .

[60]  S. Levinson,et al.  Focused review: physiatric management of HIV-related disability. , 1996, Archives of physical medicine and rehabilitation.

[61]  L. Kingsley,et al.  Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[62]  J. Chmiel,et al.  The Multicenter AIDS Cohort Study: retention after 9 1/2 years. , 1995, American journal of epidemiology.

[63]  J. Margolick,et al.  Failure of T-cell homeostasis preceding AIDS in HIV-1 infection , 1995, Nature Medicine.

[64]  M. Loveless,et al.  The HIV wasting syndrome: a review. , 1994, Journal of acquired immune deficiency syndromes.

[65]  N. Liabakk,et al.  Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters , 1994 .

[66]  J. Phair,et al.  Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. , 1993, American journal of epidemiology.

[67]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[68]  J. Bilezikian,et al.  HIV disease and the endocrine system. , 1992, The New England journal of medicine.

[69]  J. Margolick,et al.  Relationship between the immune system and frailty: Pathogenesis of immune deficiency in HIV infection and aging , 1992, Aging.

[70]  L. Fried Conference on the physiologic basis of frailty. April 28, 1992, Baltimore, Maryland, U.S.A. Introduction. , 1992, Aging.

[71]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[72]  A. Lazzarin,et al.  Elevated alpha–tumor necrosis factor levels in spinal fluid from HIV‐1–infected patients with central nervous system involvement , 1991, Annals of neurology.

[73]  R. Redfield,et al.  Induction of interleukin-6 during human immunodeficiency virus infection. , 1990, Blood.

[74]  G. Beall,et al.  Infection with HIV is associated with elevated IL-6 levels and production. , 1990, Journal of immunology.

[75]  J. Phair,et al.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.

[76]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[77]  B. Armstrong,et al.  BREAST CANCER AND SPIRONOLACTONE , 1975, The Lancet.

[78]  I. Mackay,et al.  Ageing, immune response, and mortality. , 1974, Lancet.

[79]  K. Manton,et al.  The immune system in aging: roles of cytokines, T cells and NK cells. , 2005, Frontiers in bioscience : a journal and virtual library.

[80]  M. Leal,et al.  CD4+ T-lymphocytopenia in the elderly , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[81]  S. Bandinelli,et al.  Biomarkers of frailty in older persons. , 2002, Journal of endocrinological investigation.

[82]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[83]  E. Keller,et al.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. , 2000, Annual review of medicine.

[84]  W. Strawbridge,et al.  Antecedents of frailty over three decades in an older cohort. , 1998, The journals of gerontology. Series B, Psychological sciences and social sciences.

[85]  N. Liabakk,et al.  Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters. , 1994, The Journal of infectious diseases.

[86]  C. Sherbourne,et al.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .

[87]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[88]  L. Radloff The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .